Global Gene Expression of T Cells Is Differentially Regulated by Peritoneal Dendritic Cell Subsets in an IL-2 Dependent Manner by 박채규 et al.
















†These authors have contributed
equally to this work
Specialty section:
This article was submitted to
Antigen Presenting Cell Biology,
a section of the journal
Frontiers in Immunology
Received: 31 December 2020
Accepted: 29 April 2021
Published: 17 May 2021
Citation:
Sohn M, Na HY, Shin HS, Ryu SH,
Park S, In H, Choi W, Park JS,
Hwang S, Chu MK and Park CG
(2021) Global Gene Expression of T
Cells Is Differentially Regulated by





published: 17 May 2021
doi: 10.3389/fimmu.2021.648348Global Gene Expression of T Cells Is
Differentially Regulated by Peritoneal
Dendritic Cell Subsets in an IL-2
Dependent Manner
Moah Sohn1,2†, Hye Young Na1,3†, Hyun Soo Shin1,2, Seul Hye Ryu1,2, Sejung Park1,2,
Hyunju In1,2, Wanho Choi1,2, Ji Soo Park1,2, Soomin Hwang1,2, Min Kyung Chu3
and Chae Gyu Park1,2,4,5*
1 Laboratory of Immunology, Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea,
2 Brain Korea 21 FOUR Project for Medical Science, Yonsei University College of Medicine, Seoul, South Korea, 3 Department of
Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea, 4 Therapeutic Antibody Research
Center, GENUV Inc., Seoul, South Korea, 5 Institute for Immunology and Immunological Diseases, Yonsei University College of
Medicine, Seoul, South Korea
Dendritic cells (DCs) in peripheral tissues may have a unique role to regulate innate and
adaptive immune responses to antigens that enter the tissues. Peritoneal cavity is the
body compartment surrounding various tissues and organs and housing diverse immune
cells. Here, we investigated the specialized features of classical DC (cDC) subsets
following the intraperitoneal injection of a model antigen ovalbumin (OVA). Peritoneal
cDC1s were superior to cDC2s in activating OVA-specific CD8 T cells, while both cDCs
were similar in stimulating OVA-specific CD4 T cells. Each peritoneal cDC subset
differentially regulated the homing properties of CD8 T cells. CD8 T cells stimulated by
cDC1s displayed a higher level of lung-homing receptor CCR4, whereas those stimulated
by cDC2s prominently expressed various homing receptors including gut-homing
molecules CCR9 and a4b7. Also, we found that cDC1s played a dominating role over
cDC2s in controlling the overall gene expression of CD8 T cells. Soluble factor(s)
emanating from CD8 T cells stimulated by peritoneal cDC1s were responsible for
mediating this dominance of cDC1s, and we identified IL-2 as a soluble factor
regulating the global gene expression of T cells. Collectively, our study indicates that
different peritoneal cDC subsets effectively diversify T cell responses by altering the level of
cytokines, such as IL-2, in the milieu.
Keywords: antigen presentation, dendritic cell, interleukin-2, peritoneal cavity, T cell – DC interactionsAbbreviations: Ags, antigens; APCs, antigen presenting cells; cDC, classical dendritic cells; DCs, dendritic cells; DEGs,
differentially expressed genes; GSEA, gene set enrichment analysis; IEC, intestinal epithelial cell; i.p., intraperitoneal; i.v.,
intravenous; Lin, lineage; LPL, lamina propria lymphocytes; LPS, lipopolysaccharide; medLNs, mediastinal lymph nodes;
mesLNs, mesenteric lymph nodes; OVA, ovalbumin; PBS, phosphate buffered saline; PCA, principal component analysis;
RBCs, red blood cells; Tc, CD8 cytotoxic T cell.
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Dendritic cells (DCs) are professional antigen-presenting cells
(APCs) that orchestrate innate and adaptive immune responses
(1, 2). DCs are a heterogeneous group of cells with various
subsets that are differentiated by their ontogeny, localization, and
immunological functions (3). DCs can be divided into 3 major
subsets, i.e., classical DCs (cDCs) processing and presenting
antigens (Ags) in the steady state, monocyte-derived DCs
developing and functioning under inflammatory conditions,
and plasmacytoid DCs producing type I interferon to facilitate
anti-viral immune responses. Again, cDCs are further divided
into at least 2 main subsets, cDC1s and cDC2s. cDC1s are better
at cross-presenting Ags to induce CD8 T cell responses, and
cDC2s are efficient at promoting CD4 T cells to proliferate and
differentiate (3). Distinct DC subsets have been further identified
in various tissues under different conditions, and are shown to
carry out specialized functions (4–10). Meanwhile, recent studies
have compared the transcriptomes of DC subsets in various
tissues and illustrated the commonalities and differences in their
expression of genes across tissues (11, 12), which further suggests
that DC subsets residing in particular tissues may possess unique
abilities and functions in addition to the general features of DCs.
DCs regulate and determine the type of T cell responses with
multiple signals. DCs process Ags and present them to T cells in
the form of MHC-bound peptides. The responses of cognate T
cells are further modulated by the interaction of co-stimulatory
molecules on the surface of T cells and DCs, and additionally by
the cytokine milieu (13). IL-2 is one of the important cytokines
that regulate the key aspects of T cell biology (14). IL-2 enhances
immunostimulatory responses by promoting CD4 T helper type
1 and type 2 cells as well as CD8 cytotoxic T (Tc) cells, yet it also
contributes to immunosuppressive responses by boosting the
development and function of regulatory T cells (14–17). Besides,
IL-2 also affects the durability of immune responses. Weak or
limited IL-2 signaling is critical in the formation of memory T
cells (18, 19), whereas strong IL-2 signaling, in combination with
inflammatory cytokines, induces the expression of transcription
factors T-bet and Blimp-1, which in turn promotes the
differentiation of short-lived CD8 Tc cells (20). Therefore, the
regulation of IL-2 in the milieu is important in dictating the fate
of T cells. Although it is believed that DCs have an important role
in modulating various cytokines in the milieu and thus
regulating the outcome of T cell responses (21–23), it has
remained poorly understood how and which DC subsets are
involved in controlling IL-2 in the milieu.
The peritoneal cavity is a specialized compartment enclosed
by the peritoneum that houses multiple tissues and immune cells.
Macrophages and B1 cells constitute the majority of peritoneal
immune cells, and others such as T cells, eosinophils,
neutrophils, NK cells, and DCs are found in smaller numbers
(24). Since the peritoneum is supplied with abundant blood
vessels, the peritoneal cavity is being commonly used as a
systemic injection route for small laboratory animals.
Following the intraperitoneal (i.p.) injection, peritoneal DCs
must be responsible for the capture, process, and presentation
of Ags to T cells and thus initiating immune responses; however,Frontiers in Immunology | www.frontiersin.org 2studies regarding those aspects of peritoneal DCs have been
limited. Although recent studies have characterized the diversity
of peritoneal DC subsets, the distinct roles between peritoneal
cDC subsets are yet to be investigated in depth (25–27). In the
previous study (27), we demonstrated that new subsets of
peritoneal DCs and macrophages were identified by differences
in their ability to present antigens to and thus stimulate T cells.
Our present study examines and compares the capabilities of
peritoneal cDC subsets regarding their ability to control T cell
responses, and we have discovered that peritoneal cDC1s have a
dominating role in modulating CD8 T cell responses by
upregulating the expression of IL-2.MATERIALS AND METHODS
Mice
C57BL/6J mice were purchased from Orient Bio (Seongnam,
Korea) and female mice between 6 and 12 weeks of age were used
for the experiments. C57BL/6-Tg(TcraTcrb)1100Mjb/J (OT-1),
B6.Cg-Tg(TcraTcrb)425Cbn/J (OT-2), and B6.SJL-PtprcaPepcb/
BoyJ (CD45.1) mice were obtained from the Jackson Laboratory
(Bar Harbor, ME, USA). CD45.1+ OT-1 mice were bred in house.
All mice were bred and maintained in specific pathogen-free
facilities in accordance with the guidelines approved by the
Institutional Animal Care and Use Committees of the Yonsei
University College of Medicine.
Tissue Harvest and Cell Preparation
Peritoneal exudate cells were isolated following the protocols
previously described (27). In brief, 5 ml of ice-cold isolation
buffer, DPBS containing 3% fetal bovine serum, was injected into
the peritoneal cavity. The peritoneal cavity was then gently
massaged to dislodge the attached immune cells and the
suspended peritoneal cells were harvested. The collected cell
suspension was passed through a 100 µm strainer, and the cells
were washed twice and used for experiments.
For spleen cell preparation, the spleen was mechanically
disrupted with a cell strainer and syringe plunger. Disrupted
cells were then washed twice with DPBS to filter fibrous materials
through the strainer. Red blood cells (RBCs) were lysed with
ACKlysis solution (BioLegend, San Diego, CA, USA) and washed
twice with DPBS before use (28).
For lymph node single-cell preparation, lymph nodes were
isolated and mechanically disrupted on a 100 µm cell strainer
with a syringe plunger. Fibrous materials were filtered again with
a strainer before use (29).
The isolation method of intestinal cells was modified from
protocols previously described (30). In brief, small and large
intestines were removed and placed in cold DMEM containing
5% FBS (Avantor Seradigm, Randor, USA). Mesentery lymph
nodes and Peyer’s patches were carefully removed. Intestines
were opened longitudinally and cut into 5 cm pieces and fecal
content was washed. Washed intestinal tissues were incubated
with 1 mM EDTA in DMEM at 37°C for 15 minutes stirred at
250 rpm. The supernatant containing intestinal epithelial cells
(IEC) was collected and used. To isolate the lamina propriaMay 2021 | Volume 12 | Article 648348
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DMEM containing 5% FBS, minced, resuspended in 20 ml of
DMEM containing 1 mg/ml of collagenase D (Roche, Basel,
Switzerland), 500 mg/ml of dispase, 50 mg/ml of DNase (Roche),
and 1% FBS (Avantor Seradigm), and was stirred at 250 rpm for
35 minutes at 37°C. The tissue suspension was collected and
passed through a 100 µm cell strainer, and remaining tissue
fragments were further disrupted mechanically by rubbing with a
syringe plunger. Collected lamina propria cells were washed
twice before use.
For lung cell preparation, the pulmonary circulation was
perfused with 10 ml of HBSS to remove the intravascular pool
of cells. Lungs were separated, minced thoroughly, and incubated
for 35 minutes in a digestion media containing 5 mg of
collagenase D (Roche) at 37°C. In the last 5 minutes, 10 mM
EDTA was added to quench the digesting action. Tissue
fragments were further disrupted mechanically on 100 µm cell
strainers by rubbing with a syringe plunger. The tissue
suspension passed through strainers was washed with HBSS
then RBCs were lysed with ACKlysis solution. Cells were
washed twice with HBSS before use (29).
Antibodies and Reagents
The following reagents were purchased from BioLegend: anti-
Ly6G (1A8), anti-CD3 (17A2), anti-CD19 (6D5), anti-CD115
(AFS98), anti-XCR1 (ZET), anti-CD11c (N418), anti-I-A/I-E
(anti-MHC II, M5/114.15.2), anti-CD45.1 (A20), anti-CD45.2
(104), anti-CD4 (GK1.5), anti-CD8a (53-5.8), anti-Va2 (B20.1),
anti-TCRb chain (H57-597), anti-CD11b (M1/70), anti-F4/80
(BM8), anti-B220 (RA3-6B2), anti- a4b7 (DATK32), anti-CCR9
(L053E8), anti-CD69 (H1.2F3), anti-CD25 (anti-IL-2Ra, PC61,
unless indicated otherwise), anti-CCR4 (2G12), anti-CD44
(IM7), anti-IL-2Rb (TM-b1), anti-CD49b (pan-NK cells, DX5),
recombinant mouse IL-6, recombinant mouse IL-2, anti-IL-2
(JES6-1A12), anti-SIINFEKL peptide bound to mouse H-2Kb
(25-D1.16), anti-CD14 (Sa14-2), anti-CD40 (3/23), anti-CD80
(16-10A1), anti-CD83 (Michel-19), anti-CD86 (GL-1), anti-PD-
L1 (10F.9G2), anti-PD-L2 (TY25), anti-OX40L (RM134L), anti-
H-2 (M1/42), and brefeldin A. Affinity purified polyclonal anti-
IL-2 was purchased from R&D systems (Minneapolis, MN,
USA). LPS and all trans-retinoic acid were purchased from
Sigma-Aldrich and human TGF-b1 from Peprotech (Rocky
Hill, NJ, USA). Cell Trace™ CFSE cell proliferation kit
(Thermo Fisher Scientific, Waltham, MA, USA), Cell Trace™
Violet cell proliferation kit (Thermo Fisher Scientific), LIVE/
DEAD® fixable dead cell stain kit (Thermo Fisher Scientific)
were purchased and used according to the manufacturer’s
instructions. Grade V OVA was purchased from Sigma-
Aldrich (St. Louis, MO, USA) and Endofit OVA was obtained
from InvivoGen (San Diego, CD, USA).
Flow Cytometric Analysis and Intracellular
Cytokine Staining
Cells were isolated as described in the previous section. To block
nonspecific staining, isolated single cell suspensions were
incubated with the culture supernatant of 2.4G2 (anti-CD16/
32) monoclonal antibody hybridoma for 20 minutes at 4°C. CellsFrontiers in Immunology | www.frontiersin.org 3were washed with FACS buffer (DPBS containing 2% of FBS and
2 mM EDTA), then antibodies for cell surface markers and dead
cell staining dyes were added and incubated for 20 minutes at
4°C. After surface staining, cells were washed twice and analyzed
or sorted with flow cytometry. For intracellular staining, cells
were incubated with brefeldin A for the last 4 hours before being
harvested. Cells were processed for surface staining. Then,
surface-stained cells were resuspended in Fixation/Permeabilization
solution (BioLegend) and intracellular cytokine staining was
performed according to the manufacturer’s protocol. FACSVerse™
and LSRFortessa™ flow cytometers (BD Biosciences, San Jose, CA,
USA) were used for analysis and FACSAria™ II (BD Biosciences)
was used for sorting. Flow cytometric data were analyzed with
FlowJo sofrware (FlowJo, Ashland, Oregon, USA).
Antigen Presentation
For cell culture, we used DMC7 medium composed of DMEM
containing L-glutamine, high glucose, and pyruvate (HyClone,
GE Healthcare Life Sciences, IL, USA) supplemented with 7%
fetal bovine serum (Avantor Seradigm), non-essential amino
acids (GE Healthcare Life Sciences), antibiotic-antimycotics
(GE Healthcare Life Sciences), and 57.2 mM b-mercaptoethanol
(Sigma-Aldrich) (31).
To isolate APCs, mice were injected intraperitoneally (i.p.) or
intravenously (i.v.) with soluble OVA (1.5 mg of Grade V,
Sigma-Aldrich, unless indicated otherwise), and an hour later,
peritoneal exudate cells or splenocytes were harvested as
described above. OVA-laden cDC subsets were isolated from
MHCII+ population, following the gating strategy in Figure 1A,
excluding cells expressing Lin markers (CD3, CD19, Ly6G, and
ICAM2) with the FACSAria™ II cell sorter and used for
further experiments.
For naïve T cell isolation, splenic cells from OT-1 and OT-2
mice were enriched by excluding cells expressing CD11b, CD19,
CD25, CD44, CD49b, MHCII, F4/80, B220, and CD4 (for OT-1)
or CD8 (for OT-2) using biotinylated antibodies and anti-biotin
Dynabeads (ThermoFisher Scientific). Purified T cells were
labeled with 0.5 mM CFSE or CTV (Thermo Fisher Scientific)
according to the manufacturer’s protocol.
For the antigen presentation assay, CFSE or CTV labeled T
cells and OVA-laden peritoneal APCs were co-cultured in each
well of a 96-well plate. T cells were plated at 25,000 cells, and
OVA-laden APCs were mixed with T cells at the ratio of 1:10
unless indicated otherwise. The culture volume was 250 ml. For
some experiments, blocking Abs (anti-IL-2Ra, anti-IL-2Rb, anti-
IL-2), retinoic acid, or cytokines (IL-2, IL-6, TGF-b) were treated
in written doses. Conditioned medium was made up with 60% of
the supernatant from the co-culture of peritoneal cDC subsets
and OT-1 T cells and 40% of fresh DMC7 medium.
Transwell Assay
Transwell assays were performed in flat bottom 24-well plates
with a pore size of 0.4 mm (SPL, Seoul, Republic of Korea). Each
well was filled with either a mixture of OT-1 T cells and
OVA-laden peritoneal cDC2s, or a mixture of OT-1 T cells
and OVA-laden peritoneal cDC1s as shown (Figure 2C). Total
reaction volume was 350 ml, and to make cells gather together,May 2021 | Volume 12 | Article 648348





FIGURE 1 | Peritoneal cDC subsets induce distinct T cell responses. (A) Gating strategy of cDC subsets in the peritoneal cavity. Cells expressing Lin markers (CD3, CD19 and
Ly6G) were excluded and cDCs were gated from MHCII+ cells. The percentages of each subset among cDCs are shown (representative of 4 independent experiments). (B) The
proportion of cDC subsets in the peritoneal cavity. The percentages of each subset among cDCs are shown in bar graph. Data are pooled from 4 independent experiments
(n = 4). Error bars indicate mean ± SEM. (C) Experimental outline for CD8 (D, E) and CD4 (F, G) T cell responses. 1.5 mg of Ag (OVA, Grade V) was intraperitoneally (i.p.)
injected. An hour later, OVA-laden peritoneal cDC subsets were isolated and co-cultured with either naïve OT-1 (CD8+) or OT-2 (CD4+) T cells in the ratio of 1:10 (APC:T). OT-1
T cells were analyzed on day 3, and OT-2 T cells on day 4. (D–G) CTVlo proliferated T cells are gated and shown. (D) Activation status of OT-1 T cells stimulated by peritoneal
cDC subsets. Expression of CD44, CD25, and CD69 on OT-1 T cells stimulated by peritoneal cDC subsets are shown. (E) Expression of homing molecules, a4b7 and CCR9,
on OT-1 T cells stimulated by peritoneal cDC subsets. (F) Activation status of OT-2 T cells stimulated by peritoneal cDC subsets. Expression of CD44, CD25, and CD69 on
OT-2 cells stimulated by peritoneal cDC subsets are shown. (G) Expression of homing molecules, a4b7, and CCR9 on OT-2 T cells stimulated by peritoneal cDC subsets. Data
in graphs are pooled from more than 4 (D, E) or 2 (F, G) independent experiments (n ≥ 5). Error bars indicate mean ± SEM. **p<0.01; ***p<0.001; ns, statistically not significant.Frontiers in Immunology | www.frontiersin.org May 2021 | Volume 12 | Article 6483484
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culture, upper chambers were removed and T cells from the
lower chambers were analyzed.
Antibody Array
OT-1 T cells and peritoneal cDC subsets were co-cultured for 3
days as described above. The supernatant of each co-culture
sample was collected and the expression of 308 proteins were
measured using Mouse L308 Array (Ray Biotech, Norcross, GA,
USA). The medium from OT-1 T cells cultured without any
APCs was also collected and analyzed to exclude the contents
included in the culture medium. The antibody array procedures
were performed by e-Biogen (Seoul, Republic of Korea). Global
normalization was applied using entire spot intensity.
ELISA
OT-1 T cells and OVA-laden peritoneal cDC subsets were co-
cultured for 3 days and the supernatant was collected. Then, IL-2
was measured from 100 ml of 1/10 diluted supernatant
by ELISA following the protocols provided by the
manufacturer (BioLegend).
RNA Processing and RNA-
Sequencing Analysis
OT-1 or OT-2 T cells were co-cultured with OVA-laden
peritoneal cDC subsets for 3 days as described above. Then,
the expanded cells were harvested, and RNA samples were
isolated using MiniBEST Universal RNA Extraction kit
(TaKaRA Bio, Shiga, Japan). Subsequent mRNA sequencing
procedures were performed by Macrogen, Inc (Seoul, Republic
of Korea). FPKM values are quantile normalized for comparison.
Differential gene expression analysis was performed with ExDega
(e-Biogen). Genes with a normalized value of ≤1 in all samples
were excluded and only |fold change|≥2 were selected for
differentially expressed gene analysis. Pathway analysis was
performed using GSEA (Broad Institute). Protein-protein
association network was performed with String-DB (http://
string-db.org/). RNA-Sequencing data are available from GEO
under accession number GSE150863. RNA-Sequencing data of
peritoneal cDC subsets (GEO accession number GSE130424)
were generated in our previous publication (27), and here
analyzed similarly as above.
Adoptive Cell Transfer and Homing
Index Analysis
OT-1 T cells and peritoneal cDC subsets were co-cultured for 3
days as described above. OT-1 T cells stimulated by cDC2s were
labeled with CFSE. OT-1 T cells stimulated by either cDC1s or
cDC2s with IL-2 (100 ng/ml) were labeled with CTV. 250,000
CFSE-labeled cDC2-stimulated OT-1 T cells were mixed with
250,000 CTV-labeled cDC1-stimulated OT-1 T cells and
adoptively transferred i.v. into C57BL/6J recipient mice. For
OT-1 T cells stimulated with cDC2s and cDC2s with IL-2,
500,000 OT-1 T cells from each stimulation were mixed and
adoptively transferred i.v. into C57BL/6J recipient mice. After 3
hours of adoptive transfer, CFSE-labeled vs. CTV-labeled OT-1Frontiers in Immunology | www.frontiersin.org 5T cells were detected from individual tissues, and the respective
homing index (HI) was calculated as [CTV+/CFSE+]tissue/[CTV
+/
CFSE+]input (32).Statistics
GraphPad Prism 7 and 8 (GraphPad Software, La Jolla, CA) were
used for statistical analysis. Statistical comparisons were carried
out by using the nonparametric Mann–Whitney tests unless
described otherwise. Results are expressed as means ± sem.
p<0.05 (*), p<0.01 (**), p<0.001 (***), and p<0.0001 (****)
were considered to be statistically significant.RESULTS
Peritoneal cDC1s and cDC2s Induce a
Distinct Expression of Activation and
Gut-Homing Markers on CD8 T Cells
Peritoneal cDCs can be divided into two subsets depending on
the expression of surface marker XCR1 (27). cDCs are identified
as lineage marker (Lin)-CD115-CD11c+MHCII+ in mouse
peritoneal exudate cells (PECs) (Figure 1A). Peritoneal cDCs
are composed of ca. 20% XCR1+ cDC1s and ca. 80% XCR1-
cDC2s (Figure 1B). To investigate the differences between
peritoneal cDC1s and cDC2s in regulation of T cell responses,
the expression of activation and gut-homing markers on CD4
and CD8 T cells were evaluated following stimulation with the
respective cDC subsets. Prior to isolating the cDC subsets by flow
cytometry of PECs, ovalbumin (OVA, grade V, Sigma-Aldrich)
was injected i.p. for 1 hour; then, the OVA-laden peritoneal cDC
subsets were co-cultured with OVA-specific TCR transgenic
CD8+ OT-1 or CD4+ OT-2 T cells, respectively, in the APC:T
ratio of 1:10 (Figure 1C). Both cDC1s and cDC2s were able to
induce the robust proliferation of naïve OT-1 and OT-2 T cells
(Supplementary Figures 1, 2A). However, the expression levels
of activation markers (Figure 1D and Supplementary Figure
2B) and gut-homing markers (Figure 1E and Supplementary
Figure 2B) on the proliferated (CTVlo) CD8+ OT-1 T cells were
significantly different between the stimulations with cDC1s and
cDC2s. OT-1 T cells cultured with cDC1s displayed high levels of
activation markers, CD25 and CD69, and low levels of gut-
homing markers, integrin a4b7 and CCR9, whereas those
cultured with cDC2s exhibited contrary patterns. Interestingly,
on the surface of CTVlo CD4+ OT-2 T cells, those activation
(Figure 1F and Supplementary Figure 2C) and gut-homing
markers (Figure 1G and Supplementary Figure 2C) were
expressed similarly in response to both cDC1s and cDC2s. We
compared the level of H-2Kb molecules presenting OT-1 peptide
on peritoneal cDC subsets after i.p. treatment with whole OVA
protein. Although the difference was small, the fractions of
cDC1s expressing OT-1 peptide bound to H-2Kb on surface
were higher than those of cDC2s (Supplementary Figure 3A). In
contrast, when OT-1 peptide was injected i.p., the fractions of
cDC1s expressing OT-1 peptide bound to H-2Kb on surface were
much lower than those of cDC2s (Supplementary Figure 3B).May 2021 | Volume 12 | Article 648348
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C
FIGURE 2 | Peritoneal cDC1s play a dominant role in regulating CD8 T cell responses via soluble mediators. An hour after injecting 1.5 mg of OVA (Grade V) i.p.,
OVA-laden peritoneal cDCs were isolated and co-cultured with naïve OT-1 T cells in the ratio of 1:10 (APC:T). OT-1 T cells were analyzed on day 3. (A) Expression
of CD44, CD25, CD69, a4b7, and CCR9 molecules on OT-1 T cells stimulated by peritoneal whole cDCs and cDC subsets. Live CD8+ cells are plotted and the
percentages of cells expressing each molecule among CTVlo proliferated OT-1 T cells are shown in a graph. Data are pooled from 7 independent experiments
(n ≥ 7). (B) OT-1 T cells differentiated by peritoneal cDC2s in conditioned medium. Conditioned medium contained fresh complete medium and the supernatant from
co-culture of cDC1s and OT-1 T cells in a 2:3 ratio. OVA-laden peritoneal cDC2s and OT-1 T cells were cultured under either fresh complete medium (I, control) or
conditioned medium (II). Live CD8+ T cells are plotted and the percentages of cells expressing each surface molecules are shown in graphs. Data are pooled from 2
independent experiments (n ≥ 4). (C) OT-1 T cells differentiated in 0.4 µm pore transwells. OT-1 T cells and peritoneal cDCs were co-cultured in transwells for 3 days
in combinations as shown in the table. T cells in the lower chamber were analyzed for the expression of CD25, CD69, a4b7, and CCR9. Live CD8+ T cells are
plotted and the percentages of cells expressing each molecule among CTVlo proliferated OT-1 T cells are shown in graphs. Data are pooled from more than 2
independent experiments (n ≥ 7). Error bars (A–C) indicate mean ± SEM. *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001; ns, statistically not significant.Frontiers in Immunology | www.frontiersin.org May 2021 | Volume 12 | Article 6483486
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presenting whole protein than peritoneal cDC2s. In addition,
both OT-1 T cells stimulated by peritoneal cDC1s or cDC2s
pulsed i.p. with OT-1 peptide exhibited the phenotype of OT-1 T
cells stimulated by cDC2s pulsed i.p. with OVA protein
(Supplementary Figure 4). These results suggest that, besides
the level of antigen peptide on surface, peritoneal cDC1s are
distinct from cDC2s in their antigen-presenting functions.
Meanwhile, OT-1 T cells stimulated by OVA-laden splenic
cDC1s and cDC2s exhibited the expression of surface markers
similarly (Supplementary Figure 5) as OT-1 T cells stimulated
by peritoneal cDC2s, also implying that peritoneal cDC1s might
have distinct functions.
It has been reported that grade V OVA contains a low but
detectable level of endotoxin (ca. 0.25 EU/mg) (33, 34). Therefore,
by injecting endotoxin-free OVA i.p., we examined the role of
endotoxin in the differential expression of markers on CD8+ OT-
1 T cells between the responses to cDC1s and cDC2s. When
laden i.p. with endotoxin-free OVA, both peritoneal cDC1s and
cDC2s stimulated the robust proliferation of OT-1 T cells but did
not produce the differential expression of markers thereon
(Supplementary Figure 6A). It was evident that the expression
patterns of activation and gut-homing markers on OT-1 T cells
stimulated by both cDC subsets laden with endotoxin-free OVA
were quite similar to those stimulated by cDC2s laden with grade
V OVA (i.e., low levels of activation markers and high levels of
gut-homing markers) . Meanwhi le , when 50 ng of
lipopolysaccharide (LPS), the equivalent amount of endotoxin
in grade V OVA, was injected i.p. along with endotoxin-free
OVA, OT-1 T cells cultured with cDC1s increased the expression
of activation markers and decreased the expression of gut-
homing markers but those cultured with cDC2s did not
change markedly (Supplementary Figure 6B). These findings
suggest that peritoneal cDC1s are more sensitive to the treatment
with low doses of LPS and thus better at activating OT-1 T cells.
We examined the levels of co-stimulatory molecules on
peritoneal cDC subsets after i.p. injection of PBS or LPS. The
expression of CD86 was much higher on cDC1s than on cDC2s,
but other co-stimulatory molecules were expressed higher on
cDC2s than on cDC1s (Supplementary Figure 7A). Also, the
expression level of CD86 was prominently upregulated on cDC1s
following i.p. treatment with LPS (Supplementary Figure 7B).
Then, the gene expression profiles of peritoneal cDC subsets
were analyzed from the mRNA-sequencing data of peritoneal
myeloid mononuclear cells in our previous study (27), which
indicates that TLR4 is expressed similarly between peritoneal
cDC1s and cDC2s, but the TLR4 signaling molecules are
expressed differentially (Supplementary Figures 8A, B).
Collectively, we conclude that peritoneal cDC1s possess a
unique ability to differentially regulate the expression of
various markers on CD8+ OT-1 T cells in a manner dependent
on the presence of endotoxin. Meanwhile, TGF-b, which
regulates the expression of homing receptors such as integrins
and CD69 (35), and many of the TGF-b signaling molecules are
expressed higher in peritoneal cDC2s than in cDC1s
(Supplementary Figure S8C).Frontiers in Immunology | www.frontiersin.org 7Expression of Activation and Gut-Homing
Markers on CD8 T Cells Are Dominantly
Regulated by Peritoneal cDC1s via
Soluble Mediator(s)
We also compared the expression of activation and gut-homing
markers between CD8+ OT-1 T cells cultured with peritoneal
cDC1s, cDC2, and unseparated whole cDCs. To our surprise, the
expression patterns induced by whole cDCs, comprising less
than 20% of cDC1s (Figures 1A, B), were quite identical to those
induced by cDC1s, but not by cDC2s (Figure 2A). Meanwhile,
the expression levels of those markers on CD4+ OT-2 T cells
showed no differences between the stimulations with peritoneal
cDC1s, cDC2, and whole cDCs (Supplementary Figure 9). Since
cDC1s, the smaller of the two cDC subsets, seems to dominantly
influence the expression of those markers on OT-1 T cells, we
scrutinized whether it was involved with soluble mediator(s)
emanating from the co-culture of cDC1s and OT-1 T cells. To
test this, we collected supernatants from the culture of OT-1 T
cells with peritoneal cDC1s or cDC2s, and used the conditioned
medium containing each supernatant to culture OT-1 T cells
with a respective subset of cDCs. When the conditioned medium
from the culture of OT-1 T cells with cDC1s was used, the
expression patterns of markers on OT-1 T cells stimulated by
cDC2s became similar to those stimulated by cDC1s (Figure 2B).
However, the conditioned medium from the culture of OT-1 T
cells with cDC2s did not affect the expression of markers on OT-
1 T cells stimulated by cDC1s (Supplementary Figure 10).
Therefore, cDC1s play a dominant role among whole
peritoneal cDCs in regulating the expression of markers on
OT-1 T cells via soluble mediator(s). The effect of soluble
mediator(s) was further examined using a 0.4 mm transwell co-
culture system. When co-cultured with OT-1 T cells and cDC1s
in the upper well of the transwell, the OT-1 T cells with cDC2s in
the lower well exhibited increase in the expression of CD25 and
decrease in the expression of a4b7, as compared to those co-
cultured with OT-1 T cells and cDC2s in the upper well (Figure
2C). However, the changes of CD69 and CCR9 expression on
OT-1 T cells in the lower wells were not significant, suggesting
that the soluble mediator(s) emanating from the OT-1 T cells
cultured with cDC1s was likely less abundant in the lower well of
the transwell assay than in the conditioned medium comprising
culture supernatants (Figure 2C).
IL-2 Emanating From CD8 T Cells
Regulates T Cell Responses
To identify the soluble mediator(s) that regulates the gene
expression, we compared the cytokine expression profiles
between the culture supernatants of CD8+ OT-1 T cells
stimulated by peritoneal cDC1s, cDC2s, and whole cDCs. After
screening with antibody microarray for 308 proteins, 33 proteins
were detected 1.2-fold or higher in the supernatants from OT-1 T
cells cultured with whole cDCs or cDC1s when compared to
those from OT-1 T cells cultured with cDC2s (Table 1). Then,
among these 33 proteins, we have purchased 22 commercially
available recombinant proteins and evaluated their effect on theMay 2021 | Volume 12 | Article 648348
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cDC2s. The results revealed that only IL-2 was able to modify the
expressions of a4b7, CCR9, CD25, and CD69 (Table 1 and
Figure 3A), quite as similarly as cDC1s, whole cDCs, and the
conditioned media thereof (Figures 2A, B). Among these 22
tested proteins, other than IL-2, IL-3 could modulate the
expression of a4b7, but not the other markers, on OT-1 T
cells. However, no significant change in the expression of
markers on OT-1 T cells was observed by blocking the IL-3
signal in the culture with whole cDCs (data not shown).
In a dose-dependent manner, IL-2 was able to up-regulate the
expression of activation markers CD25 and CD69, and
suppressed the levels of integrin a4b7 and CCR9 (Figure 3B).
We also verified that the expression of IL-2 was prominently
elevated in the OT-1 T cells stimulated by peritoneal cDC1s and
their culture supernatants (Figures 3C, D). Then, we validated
the role of IL-2 by blocking the IL-2 signal in OT-1 T cells
cultured with peritoneal cDC1s. The effect of each individual
antibody of anti-IL-2Ra, anti-IL-2Rb, or anti-IL-2, including
JES6-1 known to efficiently inhibit the response of CD8+ T cellsFrontiers in Immunology | www.frontiersin.org 8to IL-2 in vitro (14, 36), was not effective to reverse
the phenotype of OT-1 T cells (Supplementary Figure 11).
With the combination of anti-IL-2Ra, anti-IL2Rb, and anti-IL-2,
the level of CD69 reduced and the expression of a4b7 and CCR9
increased significantly (Figure 3E and Supplementary Figure
11). We also confirmed the effect of IL-2 on CD4+ OT-2 T cells
cultured with peritoneal cDC2s where the addition of IL-2
caused the expression of a4b7 to decrease and the expression
of CD69 to increase significantly (Supplementary Figure 12).
Signaling molecules such as retinoic acid, TGF-b, and IL-6 are
known to play an essential role in imprinting gut-homing
markers and modulating the activation status of T cells (7, 37,
38). We evaluated whether IL-2 could influence the effect of
those molecules in OT-1 T cells cultured with peritoneal cDCs.
The addition of IL-6 or TGF-b into OT-1 T cells cultured with
whole cDCs down-regulated the expression of CD25 and CD69,
and up-regulated the level of a4b7; besides, IL-6 down-regulated
CD44 expression and TGF-b up-regulated CCR9 expression,
respectively (Figure 3F). On the other hand, the addition of





Decreased a4b7 on OT-1
T with cDC2s
Decreased CCR9 on OT-1
T with cDC2s
Increased CD25 on OT-1
T with cDC2s
Increased CD69 on OT-1
T with cDC2s
Fas Ligand 1.4 1.9 No No No No
MMP-3 1.3 1.9 No No No No
Activin A 1.7 1.8 No No No No
DAN 1.3 1.7 No No No No
IL-20 1.3 1.6 No No No No
TGF-b1 1.6 1.6 No No No No
IL-17 1.8 1.6 No No No No
IL-2 1.2 1.6 Yes Yes Yes Yes
SCF 1.3 1.5 No No No No
TSLP 1.6 1.5 No No No No
Pentraxin3 1.3 1.5 No No▴ No No
Osteoprotegerin 1.3 1.5 No No No No
Granzyme G 1.3 1.4 No No▴ No No
TECK 1.2 1.4 – – – –
VEGF-D 1.3 1.4 – – – –
Eotaxin-2 1.6 1.4 No No▴ No No
L-Selectin 1.2 1.4 – – – –
Kremen-2 1.3 1.3 – – – –
TGFb3 1.2 1.3 No No No No
EG-VEGF 1.2 1.3 – – – –
IFN-g 1.5 1.3 No No No No
TL1A/TNFSF15 1.2 1.3 No No No No
CCL17 1.3 1.3 No No No No
IGFBP-3 1.2 1.3 No No No No
IGFBP-1 1.2 1.2 No No▴ No No
Decorin 1.3 1.2 – – – –
Osteoactivin 1.6 1.2 – – – –
IL-6 1.3 1.2 No No No No
IL-3 1.3 1.2 Yes No▴ No No
IFN-beta 1.3 1.2 – – – –
MMP-14/LEM-
2
1.3 1.2 – – – –
Lefty-1 1.3 1.2 – – – –
VEGFC 1.4 1.2 – – – –May 2021 |1.5 mg of OVA was given i.p. for 1 hour. OVA-laden peritoneal cDC subsets and whole cDCs were isolated and co-cultured with naïve OT-1 T cells in the ratio of 1:10 (APC:T). Each
supernatant was collected and analyzed by antibody microarray. The list includes soluble factors secreted 1.2-fold or higher in the supernatants from OT-1 T cells cultured with either
cDC1s or whole cDCs, as compared to those cultured with cDC2s. Each protein in the list shows the value of fold change and the result of its influence on OT-1 T cells cultured with cDC2s.
▴indicates the increase of CCR9 instead of the decrease.
Change to the indicated phenotype is marked as Yes in bold.Volume 12 | Article 648348
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IL-6 and TGF-b were all reverted but not those of retinoic acid
(Figure 3F). In the meantime, the dominant control of IL-2 over
the effect of IL-6 and TGF-b was also demonstrated in the culture
of OT-1 T cells with peritoneal cDC2s, where the reverting
effect of IL-2 over retinoic acid was limited to the expression of
a4b7 (Supplementary Figure 13). Therefore, IL-2 emanating
from OT-1 T cells stimulated by peritoneal cDC1s can act in a
dominant manner to regulate the expressions of activation and
gut-homing markers on T cells.
Peritoneal cDC Subsets Differentially
Regulate the Gene Expression Profiles
of T Cells
To further characterize the regulatory role of peritoneal cDCs
over T cell responses, we performed global mRNA sequencing.
CD8+ OT-1 T cells were cultured with either whole or individual
subsets of OVA-laden peritoneal cDCs in the APC:T ratio of 1:10
for 3 days. OT-1 T cells were also cultured with OVA-laden
peritoneal cDC2s in the medium containing IL-2 (cDC2s/IL-2).
Then, the gene expression profiles were analyzed and compared
between the cells in each co-culture, where almost all cells were
expanded T cells (more than 99%) but very few were cDCs
(less than 1%). Similarities and differences between the
transcriptomes of T cells cultured with peritoneal cDCs were
analyzed by principal component analysis (PCA) (Figure 4A).
The gene expression profiles of OT-1 T cells cultured with cDC1s
clustered remotely from those cultured with cDC2s, indicating
that the expression of genes in T cells are differentially regulated
by different peritoneal cDC subsets. Meanwhile, the gene
expression profiles of OT-1 T cells cultured with peritoneal
whole cDCs clustered very closely to those cultured with
peritoneal cDC1s but apart from those cultured with peritoneal
cDC2s, suggesting the superior influence of cDC1s, compared to
cDC2s, over the gene expression of T cells. We also investigated
the impact of IL-2 on the gene expression profile of OT-1 T cells
cultured with peritoneal cDC2s. In PCA, by the addition of IL-2,
OT-1 T cells cultured with peritoneal cDC2s clustered
distinctively from those cultured with peritoneal cDC subsets
without IL-2 (Figure 4A). It is notable that the first principal
component (PC1) distinguishes the OT-1 T cells stimulated by
cDC2s with IL-2 from the other clusters of those stimulated by
cDC subsets without IL-2. However, the PC2 discriminates the
OT-1 T cells stimulated by cDC2s with IL-2, clearly from those
stimulated by cDC2s without IL-2, but not from those stimulated
by cDC1s or whole cDCs without IL-2 (Figure 4A). These results
indicate that there exist IL-2 dependent and IL-2 independent
sets of genes expressed differentially between the OT-1 T cells
cultured with cDC1s versus cDC2s.
Then, we examined the differentially expressed genes (DEGs)
between OT-1 T cells cultured with cDC1s versus cDC2s (Figure
4B), where 351 genes were up-regulated in the OT-1 T cells
cultured with cDC1s and 522 genes were up-regulated in those
cultured with cDC2s (Figure 4C, upper left diagram). We also
compared the DEGs between OT-1 T cells cultured with whole
cDCs versus cDC1s, where only 54 genes were differentiallyFrontiers in Immunology | www.frontiersin.org 9expressed (Figure 4C, upper middle diagram), and those
between OT-1 T cells cultured with whole cDCs versus cDC2s,
where 538 genes were differentially regulated (Figure 4C, upper
right diagram). Notably, more than 80% of the 538 DEGs
between the OT-1 T cells cultured with whole cDCs versus
cDC2s were overlapped with the DEGs between those cultured
with cDC1s versus cDC2s (Figure 4C, lower diagram), also
suggesting the dominant role of cDC1s in controlling the gene
expression of T cells. We extended the DEG analysis to include
the OT-1 T cells stimulated by cDC2s with IL-2. Among the 464
DEGs common to both gene expression profiles of OT-1 T cells
stimulated by whole cDCs and cDC1s over those stimulated by
cDC2s, 160 genes were overlapped with the DEGs in those
stimulated by cDC2s with IL-2 over those stimulated by cDC2s
without IL-2 (Figure 4C, lower diagram). These overlapping
genes, such as Il2ra, Itga4, Itgb, and ccr9, were classified as IL-2
responsive DEGs, and non-overlapping genes as IL-2
independent DEGs (Figures 4C–E). It is notable that, while
the expression of many genes involving T cell activation and
differentiation in OT-1 T cells was distinctively affected by
the treatment of IL-2 during stimulation with peritoneal
cDC2s, the gene expression of IL-2 and CD62L was not
influenced by the treatment of IL-2 (Supplementary Figure
14). Meanwhile, we also analyzed the gene expression profiles
of OT-2 T cells stimulated by different subsets of peritoneal
cDCs. Unlike CD8+ OT-1 T cells, there existed only a few DEGs
between CD4+ OT-2 T cells cultured with different peritoneal
cDCs (Figures 4F, G).
Next, we conducted gene set enrichment analysis (GSEA) to
identify pathways and processes associated with the differential
responses of OT-1 T cells to different cDC subsets. OT-1 T cells
cultured with cDC1s were enriched with genes involving the
pathways for JAK-STAT signaling and cytokine-cytokine
receptor interaction (Figure 4H). Meanwhile, those cultured
with cDC2s were enriched with genes in the pathways
involving leukocyte transendothelial migration and actin
cytoskeleton regulation (Figure 4I). Because the numbers of
genes were not large enough for GSEA, we then analyzed the
pathways involved in IL-2 responsive and IL-2 independent
DEGs using StringDB and constructed a protein-protein
association network. In the IL-2 responsive gene set, we
identified that the up-regulated genes were involved in
cytokine-cytokine receptor interaction, such as Ifng, Lta, Fasl,
Tnf, Ccl3, Ccl4, and Ccr4, whereas the down-regulated genes were
involved in leukocyte migration, such as Itgb7, Itga4, Itgae, and
S1pr1 (Supplementary Figure 15). In the IL-2 independent gene
set, we found that the up-regulated genes were involved in
metabolic pathways, such as Cth, Acsl6, Bcat1, Polr1b, Ctps,
Ak4, Gls2, and Nos2 (Supplementary Figure 16). In addition,
we also looked into gene expression modules related to the
functional status of CD8+ T cells (39). OT-1 T cells, stimulated
by peritoneal cDC2s, up-regulated the expression of a
considerable number of genes involved in dysfunction but
fewer number of genes involved in activation. In contrast, OT-
1 T cells, stimulated by whole cDCs, cDC1s, or cDC2s with IL-2,
induced a significantly greater number of genes involved inMay 2021 | Volume 12 | Article 648348





FIGURE 3 | IL-2 produced by CD8 T cells regulates T cell responses. 1.5 mg of OVA (Grade V) was injected into the peritoneal cavity for an hour. OVA-laden peritoneal cDC
subsets were sorted and co-cultured with naïve OT-1 T cells for 3 days before analysis. (A) Expression of CD44, CD25, CD69, a4b7, and CCR9 molecules on OT-1 T cells
stimulated by peritoneal cDC2s with or without 100 ng/ml of IL-2 for 3 days. Live CTVlo CD8+ T cells are plotted and the percentages of cells expressing each molecule
among CTVlo proliferated OT-1 T cells are denoted (representative of more than 5 independent experiments). (B) Effect of graded doses of IL-2 on OT-1 T cells. OT-1 T cells
were co-cultured with peritoneal cDC2s with the indicated doses of IL-2 for 3 days. The percentages of cells expressing each molecule among CTVlo proliferated OT-1 T cells
are shown in a graph. Data are pooled from more than 3 independent experiments (n = 3). (C) Intracellular staining of IL-2. OT-1 T cells were stimulated by peritoneal cDCs for
3 days, and treated with Brefeldin A for the last 4 hours. Live CTVlo CD8+ cells are plotted and the percentages of OT-1 T cells expressing IL-2 among CTVlo proliferated OT-1
cells are shown in a graph. Data are pooled from 2 independent experiments (n = 5). (D) IL-2 was measured by ELISA from the supernatant collected from OT-1 T cells
stimulated by peritoneal cDCs for 3 days (n = 4). (E) Expression of CD44, CD69, a4b7, and CCR9 molecules on OT-1 T cells stimulated by peritoneal cDC1s while blocking
IL-2 signaling. OT-1 T cells and peritoneal cDC1s were co-cultured with antibodies blocking IL-2 signaling (2 mg/ml of polyclonal anti-IL-2, 10 mg/ml of PC61 anti-IL-2Ra, and
10 mg/ml of TmB1 anti-IL-2Rb) for 3 days. Live CTVlo CD8+ T cells are plotted and the percentages of cells expressing each molecule among CTVlo proliferated OT-1 T cells
are shown in a graph. Data are pooled from 3 independent experiments (n = 5). (F) Effect of IL-2 and other immunomodulating molecules. OT-1 T cells and peritoneal whole
cDCs were co-cultured with or without 1 µg/ml of IL-2 under specified conditions (20 ng/ml of IL-6, 6 ng/ml of TGF-b, or 20 µM of ATRA). The percentages of cells expressing
each molecule among CTVlo proliferated OT-1 T cells are shown in graphs. Data are pooled from 2 independent experiments (n ≥ 5). Error bars (B–F) indicate mean ± SEM.
*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001; ns, statistically not significant.Frontiers in Immunology | www.frontiersin.org May 2021 | Volume 12 | Article 64834810
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regulated genes in OT-1 T cells stimulated by cDC2s with IL-2
were rather different from those in OT-1 T cells stimulated by
whole cDCs and cDC1s (Figure 4J). Thus, peritoneal cDC2s
likely cause the dysfunction of OT-1 T cells, while cDC1s
contribute to the activation of OT-1 T cells via controlling the
expression of a large number of genes in IL-2 dependent as well
as IL-2 independent manners. All in all, our analyses reveal the
distinctive features of peritoneal cDC1s and cDC2s that regulate
the gene expression in CD8+ OT-1 T cells.
Different Subsets of Peritoneal cDCs
Induce Distinct Homing Properties
of T Cells
Since the expression of gut-homing markers, a4b7 and CCR9,
on CD8+ OT-1 T cells was differentially regulated between the
stimulation with peritoneal cDC1s and cDC2s, we further
examined the expression of other integrins and chemokine
receptors. Integrins are expressed on cell surfaces as
heterodimers formed by a and b subunits. An integrin a4 can
form heterodimers with either integrin b1 or b7, while integrin
b7 can be paired with either integrin a4 or ae (Supplementary
Figure 17). In particular, the heterodimers formed with integrin
b7 play critical roles in gut trafficking of leukocytes (40).
Therefore, we examined the expression of individual integrin
subunits on OT-1 T cells following stimulation with peritoneal
cDCs (Figure 5A and Supplementary Figures 18, 19). In
accordance with their expression of a4b7, both integrin
subunits a4 and b7 were expressed on OT-1 T cells stimulated
by cDC2s. Meanwhile, OT-1 T cells stimulated by cDC2s with
IL-2 sharply down-regulated the expression of integrin b7.
Similarly, OT-1 T cells stimulated by whole cDCs and cDC1s
failed to express integrin b7 but maintained the expression of
integrin a4 on the cell surface. Additional evaluation of integrins
ae and b1, the other binding partners of integrins b7 and a4
respectively, revealed that cDC2s up-regulated both integrins ae
and b1 on OT-1 T cells, whereas whole cDCs, cDC1s, and cDC2s
with IL-2 induced b1 but not ae (Figure 5A and Supplementary
Figures 18, 19). Collectively, the expression of integrins b7 and
ae, best known for gut-homing properties, on CD8+ OT-1 T cells
was sustained by peritoneal cDC2s but suppressed by cDC1s or
cDC2s with IL-2.
We also examined the influence of peritoneal cDCs on the
expression of chemokine receptor genes in OT-1 T cells
(Supplementary Figure 20). In addition to CCR9, the
stimulation with peritoneal cDC2s strongly induced the gene
expression of Cxcr3, Cxcr4, Cxcr6, and Xcr1, which are homing
receptors to multiple organs including both lymphoid and non-
lymphoid tissues (41, 42). Peritoneal cDC1s significantly up-
regulated the gene expression of Ccr4, Ccr6, and Ccr8, known to
be important in homing to the lung and the skin (32, 41, 42).
Meanwhile, OT-1 T cells stimulated by cDC2s with IL-2
increased the gene expression of more diverse chemokine
receptors, including Ccr2, Ccr3, Ccr4, Ccr5, Ccr10, Cxcr3,
Cxcr4, and Cxcr6 (Supplementary Figure 20). Then, we
assessed the surface expression of chemokine receptors andFrontiers in Immunology | www.frontiersin.org 11confirmed the augmented expression of CCR4 on the surface
of OT-1 T cells stimulated by cDC1s as compared to those
stimulated by cDC2s (Figure 5B). The low expression of CCR4
on OT-1 T cells stimulated by cDC2s was influenced by
treatment of the conditioned medium from the culture of OT-
1 T cells with cDC1s (Supplementary Figure 21). We then
demonstrated that the addition of IL-2 to the culture with cDC2s
significantly up-regulated the expression of CCR4 on OT-1 T
cells (Figure 5C), and that the inhibition of IL-2 signaling
significantly reduced the expression of CCR4 on OT-1 T cells
cultured with cDC1s (Figure 5D). Therefore, the level of CCR4
on CD8+ OT-1 T cells are up-regulated by the stimulation with
peritoneal cDC1s in an IL-2 dependent manner. Meanwhile, the
expression of TGF-b and TGF-b signaling molecules, which
regulate the expression of homing receptors (35), in OT-1 T
cells is not markedly affected by the stimulation with different
peritoneal cDC subsets and IL-2 (Supplementary Figure 22).
To determine whether OT-1 T cells stimulated by different
peritoneal cDC subsets possess distinct properties to migrate into
peripheral tissues in vivo, we examined their homing capacities
using competitive adoptive transfer experiments (32). OT-1 T
cells stimulated and expanded by 2 different peritoneal cDC
subsets were labeled respectively with 2 different fluorescent dyes
(i.e., CFSE and CTV), mixed in an equal ratio, and then
adoptively transferred intravenously into recipient mice. At 3
hours following adoptive transfer, various lymphoid and
peripheral tissues were harvested and analyzed for the presence
of fluorescently labeled OT-1 T cells. The HI (the ratio of [CTV+
cells/CFSE+ cells] in tissue to [CTV+ cells/CFSE+ cells] in input)
indicated that OT-1 T cells stimulated by cDC2s were able to
traffic to various tissues, including the mediastinal lymph nodes
(medLNs), mesenteric lymph nodes (mesLNs), spleen, and lungs,
while those stimulated by cDC1s migrated preferentially to the
lung but poorly to the lymphoid tissues (Figure 5E, upper panels).
When the migration of OT-1 T cells was compared between the
cultures with cDC2s versus cDC2s with IL-2, both groups of OT-1
T cells were able to migrate to various tissues (Figure 5E, lower
panels). It was notable that none of the adoptively transferred OT-
1 T cells were detected in exudates from the peritoneal cavity
(Figure 5E). In addition, despite the significantly elevated levels of
gut-homing molecules on OT-1 T cells stimulated by cDC2s, none
of those were detectable in the gut tissues (Supplementary Figure
23). These results suggest that OT-1 T cells stimulated by cDC1s
express lung-homing molecules, such as CCR4, as the dominant
homing mechanism, whereas those stimulated by cDC2s support
broad homing properties.DISCUSSION
Upon stimulation with APCs, T cells undergo several changes. T
cells become activated, differentiate into specific subsets, and
alter their tissue-specific homing molecules (41, 43, 44). We
evaluated these features of T cells stimulated by peritoneal cDC
subsets and found that different cDC subsets made differences in
the expression of activation and homing receptors on CD8+ OT-1May 2021 | Volume 12 | Article 648348
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FIGURE 4 | Gene expression profiles of T cells are differentially regulated by peritoneal cDC subsets. 1.5 mg of OVA (Grade V) was injected into the peritoneal cavity
for an hour. OVA-laden peritoneal cDC subsets were isolated and co-cultured with either naïve OT-1 or OT-2 T cells for 3 days before performing mRNA-sequencing
for the transcriptional profiling analyses. Transcriptional profiling analyses were also performed for OT-1 T cells co-cultured with OVA-laden peritoneal cDC2s in 100
ng/ml of IL-2 for 3 days. (A) PCA analysis of OT-1 T cells stimulated by peritoneal cDCs. (B) Heatmap of the 873 differentially expressed genes (log2 fold change >1)
between OT-1 T cells stimulated by peritoneal cDC1s and cDC2s. Two replicates per subset are shown. Color scale depicts z-score. (C) Venn diagram shows the
overlap between genes with fold change > 2 in OT-1 T cells stimulated by peritoneal cDCs. Number of genes that are increased (up-arrow, red), decreased (down-
arrow, blue), or contra regulated (no-arrow, black) are shown. (D) Scatter plot of log intensity comparing gene expression between OT-1 T cells stimulated by
peritoneal cDC1s and cDC2s. Top 10 genes differentially expressed (black) and Il2ra, Cd69, Itga4, Itgb7, and Ccr9 (red) are shown. The genes within green boxes
are IL-2 responsive and blue boxes are IL-2 independent. (E) Expression (normalized value, log2) of Cd44, Il2ra, Cd69, Itga4, Itgb7, and Ccr9 in OT-1 T cells
stimulated by peritoneal cDCs (n = 2). (F) Heatmap of the 58 differentially expressed genes (log2 fold change >1) between OT-2 T cells stimulated by peritoneal
cDC1s and cDC2s. Two replicates per subset are shown. Color scale depicts z-score. (G) Number of differentially expressed genes (log2 fold change >1) that are
increased (up-arrow, red), or decreased (down-arrow, blue) in OT-2 T cells stimulated by peritoneal cDCs are shown. (H, I) Enriched pathway analysis using the C7
GSEA collection (ImmunoSigDB). (H) Representative enrichment plot from OT-1 T cells stimulated by peritoneal cDC1s compared to cDC2s,
“JAK_STAT_signaling_pathway” and “Cytokine_cytokine_receptor_interaction”. (I) Representative enrichment plot from OT-1 T cells stimulated by peritoneal cDC2s
compared to cDC1s, “Leukocyte_transendothelial_migration” and “Regulation_of_actin_cytoskeleton”. (J) Heatmap of the genes involved in CD8 T cell status.
Sohn et al. Differential Regulation of T CellsT cells. Stimulation with cDC1s was superior in activating OT-1 T
cells. Also, cDC1s promoted the lung-homing capacity of OT-1 T
cells while cDC2s increased the expression of gut-homing
molecules on the surface. Like all other tissues, the peritoneal
cavity contains a much smaller number of cDC1s than that of
cDC2s within the whole cDC population. However, the
phenotypic and functional outcomes of whole peritoneal cDCs
were quite similar to those of peritoneal cDC1s. Global mRNA-
sequencing analysis of transcriptomes also confirmed that the
overall gene expression profile of OT-1 T cells stimulated by
whole cDCs were similar to those stimulated by cDC1s but not
cDC2s. Therefore, our study demonstrates that peritoneal cDC1s
play a dominant role over other cDCs in controlling the responses
of CD8+ OT-1 T cells.
The cytokine milieu is important for the differentiation of T
cells. It is shown that TCR-stimulated T cells and bystander T
cells are differentially influenced and polarized in the culture
containing IL-2 (45). Recent studies on the cytokine milieus that
lead the differentiation of T cells into specific subsets indicated
that DCs actively take part in generating such conditions. DCs
can directly secrete certain cytokines and/or modulate the
response to specific cytokines (22, 23). DCs can also indirectly
regulate the level of particular cytokines by inducing T cells to
secrete and/or to consume those cytokines (21, 22). Besides,
CD25 on Ag-presenting DCs can participate in trans-
presentation of IL-2 to Ag-responding T cells (14, 46).
Meanwhile, IL-2 immunotherapy is found to expand and
activate the population of DCs, and thus boost immunity (47).
Our present study illustrated that peritoneal cDC1s, but not
cDC2s, are able to promote OT-1 T cells to secrete a high level of
IL-2. Although the increased level of IL-2 modulates the gene
expression profile of OT-1 T cells stimulated by cDC2s to mimic
that of OT-1 T cells stimulated by cDC1s, a significant number of
genes are still regulated by cDC2s independently of IL-2. In fact,
IL-2 is a complicated cytokine producing different outcomes
depending on the type, strength, and duration of signals (14, 48).
For example, a strong IL-2 signal, in combination with
inflammatory cytokines , induces the expression of
transcription factor T-bet and Blimp-1, which in turn
promotes the differentiation of short-lived effector CD8 T cells
(20). On the other hand, weak IL-2 signals are involved in theFrontiers in Immunology | www.frontiersin.org 13formation of memory T cells (18, 19). Thus, we cannot exclude
the possibility that DEGs between the stimulations with cDC1s
and cDC2s with IL-2 may be due to the inadequate dose and/or
the prolonged duration of IL-2 signals. In addition, other
modulating factors derived from cDC1s may act on T cells
synergistically and/or cooperatively with IL-2, which requires
further studies.
We also discovered that peritoneal cDC1s and whole cDCs
induce OT-1 T cells to up-regulate CCR4, a chemokine receptor
for lung and inflamed tissues (41, 42), and to down-regulate
a4b7 and CCR9, homing molecules for gut tissues (49, 50), in an
IL-2 dependent manner. On the other hand, peritoneal cDC2s
induce OT-1 T cells to express a variety of chemokine receptors
and integrins, homing molecules for various tissues, as well as
CD62L, a homing receptor for lymphoid tissues. Consistent with
this observation, in competitive adoptive transfer assays, most of
the OT-1 T cells activated by cDC1s migrate into the lung,
whereas those stimulated by cDC2s migrate into various
lymphoid tissues as well as the lung. In the meantime, T cells
activated by cDC2s with IL-2 show the homing properties of T
cells induced by both peritoneal cDC1s and cDC2s. They down-
regulate gut-homing molecules but up-regulate both CCR4 and
various other chemokine receptors expressed by OT-1 T cells
stimulated by cDC2s. Accordingly, their homing properties are
not limited to the lung but also able to migrate into various
lymphoid tissues. Notably, despite the augmented expression of
gut-homing molecules, OT-1 T cells stimulated by cDC2s are
unable to migrate into gut tissues in competitive adoptive
transfer assays. Besides these findings, no significant gut-
homing properties of OT-1 T cells are observed following
adoptive transfer into the recipient mice treated with OVA and
IL-2 (data not shown).
The mechanisms of how different peritoneal cDC subsets lead
to the different outcomes of CD8+ T cell responses are not fully
recognized in vivo. It is notable that, although the expression of
TGF-b in OT-1 T cells is not influenced by the stimulation with
different peritoneal cDC subsets, TGF-b is expressed higher in
peritoneal cDC2s than in cDC1s. Since TGF-bmediates complex
effects on the immune system by dampening or promoting T cell
responses as well as regulating the expression of integrins and
CD69 (35, 38, 51), the different expression of TGF-b betweenMay 2021 | Volume 12 | Article 648348
Sohn et al. Differential Regulation of T Cellsperitoneal cDC subsets might also be involved in controlling the
differential expression of genes in CD8+ T cells. Interestingly, the
dominant feature of cDC1s on controlling the responses of Ag-
responding CD8+ T cells is only observed when a small amountFrontiers in Immunology | www.frontiersin.org 14of LPS is co-delivered i.p. with the Ag, indicating that peritoneal
cDC1s are better at activating OT-1 T cells, in part, because they
are more sensitive to LPS. Although the expression of TLR4 gene




FIGURE 5 | Peritoneal cDCs induce CD8 T cells with distinct homing properties. 1.5 mg of OVA (Grade V) was injected into the peritoneal cavity for an hour. OVA-laden peritoneal
cDC subsets were isolated and co-cultured with naïve OT-1 T cells for 3 days before analysis. (A)OT-1 T cells stimulated by cDCs were stained for integrins a4, b7, ae, and b1
(representative of more than 3 independent experiments). (B) Surface expression of CCR4 in OT-1 T cells stimulated by peritoneal cDCs are shown (representative of 4 independent
experiments). (C) Effect of IL-2 on CCR4 expression. OT-1 T cells and peritoneal cDC2s were co-cultured with or without 100 ng/ml of IL-2 for 3 days. Live CTVlo CD8+ T cells are
plotted and the percentages of cells expressing CCR4 among CTVlo proliferated OT-1 T cells are shown in a graph. Data are pooled from 2 independent experiments (n ≥ 6). Error
bars indicate mean ± SEM. (D) Expression of CCR4 on OT-1 T cells stimulated by peritoneal cDC1s while blocking IL-2 signaling. OT-1 T cells and peritoneal cDC1s were co-
cultured with antibodies blocking IL-2 signaling (2 mg/ml of polyclonal anti-IL-2, 10 mg/ml of PC61 anti-IL-2Ra, and 10 mg/ml of TmB1 anti-IL-2Rb) for 3 days. Live CTVlo CD8+ T cells
are plotted and the percentages of cells expressing CCR4 among CTVlo proliferated OT-1 T cells are shown in a graph. Data are pooled from 2 independent experiments (n ≥ 4).
Error bars indicate mean ± SEM. (E)Homing index (HI) measured by competitive adoptive transfer experiments. OT-1 T cells were stimulated by cDC2s (labeled with CFSE), cDC1s
(labeled with CTV), or cDC2s plus IL-2 (labeled with CTV). Labeled OT-1 T cells were mixed 1:1 and adoptively transferred intravenously (i.v.) into recipient mice. A total of 500,000
cells containing an equal mixture of OT-1 T cells respectively stimulated by cDC1s vs. cDC2s (upper panels) or a total of 1,000,000 cells containing an equal mixture of OT-1 T cells
respectively stimulated by cDC2s plus IL-2 vs. cDC2s (lower panels) were adoptively transferred. After 3 hours of competitive adoptive transfer, HI of each tissue was determined.
HI was calculated as [CTV+/CFSE+]tissue/[CTV
+/CFSE+]input. Graph shows means of 2 HI values from 2 independent experiments. *p<0.05; **p<0.01.May 2021 | Volume 12 | Article 648348
Sohn et al. Differential Regulation of T Cellsmolecules are expressed differently. Also, the higher expression
and induction of CD86 on peritoneal cDC1s are notable, while
other co-stimulatory molecules are expressed higher on
peritoneal cDC2s with/without LPS treatment. Meanwhile,
peritoneal cDC subsets did not induce distinct CD8 T cell
responses nor showed dominance over each other when Ag
and LPS was co-delivered in vitro (data not shown). This likely
suggests that, to acquire the dominant feature, cDC1s need
maturation stimuli directly as well as indirectly from the
in vivo treatment of LPS. It will be important to elucidate the
nature of stimulating signals inside the peritoneal cavity that
maturate cDC1s and the underlying mechanisms of how
different cDC subsets lead to distinct T cell responses.DATA AVAILABILITY STATEMENT
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